Previous 10 | Next 10 |
Thorne HealthTech ( NASDAQ: THRN ) said its blood collection device OneDraw was certified in Japan as a medical device after being cleared by the Pharmaceutical and Medical Devices Agency (PMDA). "We appreciate the help from our partners in Japan because we believ...
Thorne HealthTech's OneDraw™ Blood Collection Device Receives PMDA Certification in Japan PR Newswire NEW YORK , Aug. 23, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN), a leader in developing innovati...
Image source: The Motley Fool. Thorne HealthTech, Inc. (NASDAQ: THRN) Q2 2022 Earnings Call Aug 10, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Thorne HealthTech, Inc. (THRN) Q2 2022 Earnings Call Transcript
Thorne HealthTech, Inc. (THRN) Q2 2022 Earnings Conference Call August 10, 2022 08:00 AM ET Company Participants Thomas Wilson - Vice President, Investor Relations Paul Jacobson - Chief Executive Officer Bryan Conley - Chief Financial Officer Michelle Crow - ...
The following slide deck was published by Thorne HealthTech, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Thorne HealthTech, Inc. 2022 Q2 - Results - Earnings Call Presentation
Thorne HealthTech press release ( NASDAQ: THRN ): Q2 Non-GAAP EPS of -$0.05 (vs. $0.22 Y/Y). Revenue of $56.1M (+30.8% Y/Y). FY22 guidance revised to net sales of $235M to $242M (vs. consensus of $247.13M) and EPS of of $0.36 to $0.39 (vs. consensus of $0.34). ...
Thorne HealthTech Reports Second Quarter 2022 Results PR Newswire Revises Full-Year 2022 Guidance NEW YORK , Aug. 9, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ: THRN), a leader in developi...
Thorne HealthTech Announces Two-Year Collaboration with AstraZeneca on Disease Discovery System to Advance Novel Drug Discovery PR Newswire NEW YORK , Aug. 4, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN), a...
Thorne HealthTech Achieves Self-Affirmed GRAS Status for Nicotinamide Riboside Malate PR Newswire NEW YORK , July 19, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN), a leader in developing innovative solution...
Thorne HealthTech Announces Second Quarter 2022 Earnings Release Date and Conference Call PR Newswire NEW YORK , July 19, 2022 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in developing innovative solutions for a personalized appr...
News, Short Squeeze, Breakout and More Instantly...
Thorne Healthtech Inc. Company Name:
THRN Stock Symbol:
NASDAQ Market:
Thorne Healthtech Inc. Website:
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Thorne Healthtech Inc. (THRN) is expected to report for Q3 2023
L Catterton Completes Acquisition of Thorne HealthTech, Inc. PR Newswire NEW YORK , Oct. 16, 2023 /PRNewswire/ -- L Catterton, a leading global consumer-focused investment firm, today announced the successful completion of its acquisition of Thorne ...